
A lower dose of Pfizer’s coronavirus vaccine is 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11, according to new clinical trial data from the company. The data was given to the U.S. Food and Drug Administration on Friday, and the agency is expected to release its own analysis of the trial… read on > read on >